These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 2448367

  • 1. The effects of aprotinin, a kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
    Madeddu P, Oppes M, Soro A, Dessi'-Fulgheri P, Glorioso N, Bandiera F, Manunta P, Rubattu S, Rappelli A.
    J Hypertens; 1987 Oct; 5(5):581-6. PubMed ID: 2448367
    [Abstract] [Full Text] [Related]

  • 2. The effects of aprotinin, a glandular kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
    Madeddu P, Oppes M, Soro A, Dessi'-Fulgheri P, Glorioso N, Manunta F, Rubatti S, Rappelli A.
    Agents Actions Suppl; 1987 Oct; 22():373-80. PubMed ID: 2449054
    [Abstract] [Full Text] [Related]

  • 3. The effect of aprotinin (a serine protease inhibitor) on renal function and renin release.
    Seto S, Kher V, Scicli AG, Beierwaltes WH, Carretero OA.
    Hypertension; 1983 Oct; 5(6):893-9. PubMed ID: 6197374
    [Abstract] [Full Text] [Related]

  • 4. Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake.
    Levy SB, Lilley JJ, Frigon RP, Stone RA.
    J Clin Invest; 1977 Jul; 60(1):129-38. PubMed ID: 874078
    [Abstract] [Full Text] [Related]

  • 5. The role of renal kallikrein and prostaglandin in the control of renin release.
    Suzuki S, Kobayashi M, Hashiba K.
    Jpn Heart J; 1986 Jan; 27(1):83-93. PubMed ID: 2425102
    [Abstract] [Full Text] [Related]

  • 6. Urinary kallikrein in normal renin essential hypertension.
    Lawton WJ, Fitz AE.
    Circulation; 1977 Nov; 56(5):856-9. PubMed ID: 912848
    [Abstract] [Full Text] [Related]

  • 7. Reduced activity of the kallikrein-kinin system predominates over renin-angiotensin system overactivity in all conditions of sodium balance in essential hypertensives and family-related hypertension.
    Sànchez R, Nolly H, Giannone C, Baglivo HP, Ramírez AJ.
    J Hypertens; 2003 Feb; 21(2):411-7. PubMed ID: 12569273
    [Abstract] [Full Text] [Related]

  • 8. Antihypertensive and renal effects of captopril in spontaneously hypertensive rats: evidence against a role of the kallikrein-kinin system.
    Filep J, Rigter B, Földes-Filep E.
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):222-7. PubMed ID: 2441174
    [Abstract] [Full Text] [Related]

  • 9. Modulation of urinary kallikrein and plasma renin activities does not affect established hypertension in the fawn-hooded rat.
    Gilboa N, Rudofsky UH, Phillips MI, Magro AM.
    Nephron; 1989 Aug; 51(1):61-6. PubMed ID: 2644567
    [Abstract] [Full Text] [Related]

  • 10. Effect of the serine protease inhibitor, aprotinin, on systemic haemodynamics and renal function in patients with hepatic cirrhosis and ascites.
    MacGilchrist A, Craig KJ, Hayes PC, Cumming AD.
    Clin Sci (Lond); 1994 Sep; 87(3):329-35. PubMed ID: 7525142
    [Abstract] [Full Text] [Related]

  • 11. Role of renal kallikrein in control of renin release in conscious rats.
    Kobayashi M, Suzuki S, Hashiba K.
    Am J Physiol; 1983 Mar; 244(3):E262-5. PubMed ID: 6187220
    [Abstract] [Full Text] [Related]

  • 12. Studies on the natriuretic effect of nifedipine in hypertensive patients: increase in levels of plasma atrial natriuretic factor without participation of the renal kallikrein-kinin system.
    Rappelli A, Dessì-Fulgheri P, Madeddu P, Glorioso N.
    J Hypertens Suppl; 1987 Dec; 5(4):S61-5. PubMed ID: 2450187
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Urinary kallikrein and systemic prostacyclin synthesis during sodium chloride infusion in normal man.
    Watson ML, Cumming AD, Lambie AT, Oates JA.
    Clin Sci (Lond); 1985 May; 68(5):537-43. PubMed ID: 3884237
    [Abstract] [Full Text] [Related]

  • 15. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K, Yasujima M, Chiba S, Sato M, Irokawa N, Imai Y, Yoshinaga K.
    Adv Exp Med Biol; 1979 May; 120B():487-501. PubMed ID: 517244
    [Abstract] [Full Text] [Related]

  • 16. Urinary kallikrein in normotensive subjects and in patients with essential hypertension.
    Zschiedrich H, Fleckenstein P, Geiger R, Fink E, Sinterhauf K, Philipp T, Distler A, Wolff HP.
    Clin Exp Hypertens (1978); 1980 May; 2(3-4):693-708. PubMed ID: 7000466
    [Abstract] [Full Text] [Related]

  • 17. Effect of sodium depletion on active renin, inactive renin and prekallikrein in plasma and urinary kallikrein excretion in glomerulonephritic patients.
    Tsai TJ, Chen WY, Yen TS.
    J Formos Med Assoc; 1990 May; 89(5):341-5. PubMed ID: 1977841
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Active kallikrein response to changes in sodium-chloride intake in essential hypertensive patients.
    Ferri C, Bellini C, Carlomagno A, Desideri G, Santucci A.
    J Am Soc Nephrol; 1996 Mar; 7(3):443-53. PubMed ID: 8704111
    [Abstract] [Full Text] [Related]

  • 20. Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension.
    Seino M, Abe K, Irokawa N, Ito T, Yasujima M, Sakurai Y, Chiba S, Saito K, Ritz K, Kusaka T, Miyazaki S, Yoshinaga K.
    Tohoku J Exp Med; 1978 Mar; 124(3):197-203. PubMed ID: 635897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.